PRSS3 and hepatocellular carcinoma: Epigenetic dysregulation of PRSS3-V2 distinct between mPRSS3-V2Low in early clinical stages and umPRSS3High in advanced tumors has potential diagnostic value for patients with early HCC (Figure 7).